Nvidia Beats Earnings Expectations as AI Demand Drives Record Growth 
ECB Signals Possible Rate Hike as Iran Conflict Fuels Inflation Concerns 
SpaceX Eyes AI Computing Expansion Ahead of Historic IPO 
Goldman Sachs Sees Stronger U.S. Dollar as Global Economic Gaps Widen 
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026 
Spying, Southampton and economic pressure cooker of the ‘richest match in football’ 
Rubio, Jaishankar Discuss Iran Crisis, Trade, and Energy Security During Key U.S.-India Talks 
AI-Driven Memory Chip Prices May Be Skewing U.S. Inflation Data, Fed Minutes Suggest 
World Bank Emergency Funding Demand Surges as 27 Countries Seek Crisis Support Amid Iran Conflict 
OpenAI Expands Globally with First Overseas AI Lab in Singapore 
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks 
Rupee Rebounds as RBI Signals Strong Support Amid Falling Oil Prices 
European Stocks Rise as U.S.-Iran Peace Deal Hopes Lift Market Sentiment 
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations 
Marco Rubio Visits India to Rebuild U.S.-India Ties Amid Trade and Geopolitical Tensions 
X Corp Loses Legal Battle Over Australia Child Safety Fine 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
